1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
NATION-WIDE POPULATION-BASED STUDY ON 15-YEAR MORTALITY IN PROSTATE CANCER ACCORDING TO RISK CATEGORIES IN THE NATIONAL PROSTATE CANCER REGISTER (NPCR) OF SWEDEN
2011) 26th Annual Congress of the European Association of Urology In European Urology Supplements 10(2). p.324-325(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer.
(
- Contribution to journal › Article
-
Mark
Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia
(
- Contribution to journal › Article
-
Mark
COMPARING TESTOSTERONE AND PSA FOR DIFFERENT BASELINE TESTOSTERONE CONCENTRATIONS DURING INITIATION OF DEGARELIX AND LEUPROLIDE TREATMENT
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.130-130(
- Contribution to journal › Published meeting abstract
- 2003
-
Mark
A systematic overview of radiation therapy effects in urinary bladder cancer
(
- Contribution to journal › Article
- 2002
-
Mark
Hereditary prostate cancer: clinical characteristics and survival
(
- Contribution to journal › Article
- 2000
-
Mark
Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer
(
- Contribution to journal › Article